$BIIB News Speculators turn the heat up to ‘so
Post# of 102240
Posted On: 01/22/2014 3:27:30 PM
$BIIB News
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biogen shares hit new high as Tecfidera sales crush estimates 10:50 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Biogen Idec profit up 22% on Tecfidera sales boost 8:09 a.m. Oct. 28, 2013 - MarketWatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside 8:54 a.m. Today - 247WallSt.com
Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14) 6:36 a.m. Today - Seeking Alpha
Biogen Idec Now #53 Largest Company, Surpassing Occidental Petroleum 4:41 p.m. Jan. 21, 2014 - TheStreet.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 9:49 a.m. Jan. 21, 2014 - TheStreet.com
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry 7:19 a.m. Jan. 21, 2014 - Seeking Alpha
Can JNJ Keep the Earnings Streak Alive? - Analyst Blog 3:12 p.m. Jan. 20, 2014 - Zacks.com
Biogen Idec: 4 Different Insiders Have Sold Shares This Year 1:14 a.m. Jan. 20, 2014 - Seeking Alpha
GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market 2:05 p.m. Jan. 19, 2014 - Seeking Alpha
Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Jan. 17, 2014 - TheStreet.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
Generic Unit at Perrigo Looks Promising - Analyst Blog 11:30 a.m. Jan. 17, 2014 - Zacks.com
Insider Trading Alert - BIIB, MDAS, SPLK, IBKR And AMTD Traded By Insiders 10:30 a.m. Jan. 17, 2014 - TheStreet.com
Interesting BIIB Put And Call Options For February 14th 11:20 a.m. Jan. 16, 2014 - TheStreet.com
Biogen, Celgene Lead 5 Top Large-Cap Drugmakers 7:05 a.m. Jan. 15, 2014 - Investors Business Daily
9 Biotechnology Stocks to Buy Now 6:30 a.m. Jan. 15, 2014 - InvestorPlace.com
ACOR Preliminary Q4 Revs Look Good - Analyst Blog 11:40 a.m. Jan. 14, 2014 - Zacks.com
Merck Turnaround Is Working Out Well 11:15 a.m. Jan. 14, 2014 - Barrons.com
Facebook, Other Big Cap 20 Leaders Fall In Low Volume 5:49 p.m. Jan. 13, 2014 - Investors Business Daily
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 4:00 p.m. Jan. 2, 2014 - BusinessWire
Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma 8:00 a.m. Dec. 31, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice 8:00 a.m. Dec. 17, 2013 - BusinessWire
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe 2:00 a.m. Dec. 17, 2013 - BusinessWire
Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America 8:00 a.m. Dec. 13, 2013 - PR Newswire
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biogen shares hit new high as Tecfidera sales crush estimates 10:50 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Biogen Idec profit up 22% on Tecfidera sales boost 8:09 a.m. Oct. 28, 2013 - MarketWatch.com
Earnings season focus shifts to revenue, capex 9:52 a.m. Oct. 27, 2013 - Wallace Witkowski
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside 8:54 a.m. Today - 247WallSt.com
Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14) 6:36 a.m. Today - Seeking Alpha
Biogen Idec Now #53 Largest Company, Surpassing Occidental Petroleum 4:41 p.m. Jan. 21, 2014 - TheStreet.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 9:49 a.m. Jan. 21, 2014 - TheStreet.com
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry 7:19 a.m. Jan. 21, 2014 - Seeking Alpha
Can JNJ Keep the Earnings Streak Alive? - Analyst Blog 3:12 p.m. Jan. 20, 2014 - Zacks.com
Biogen Idec: 4 Different Insiders Have Sold Shares This Year 1:14 a.m. Jan. 20, 2014 - Seeking Alpha
GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market 2:05 p.m. Jan. 19, 2014 - Seeking Alpha
Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Jan. 17, 2014 - TheStreet.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com
Generic Unit at Perrigo Looks Promising - Analyst Blog 11:30 a.m. Jan. 17, 2014 - Zacks.com
Insider Trading Alert - BIIB, MDAS, SPLK, IBKR And AMTD Traded By Insiders 10:30 a.m. Jan. 17, 2014 - TheStreet.com
Interesting BIIB Put And Call Options For February 14th 11:20 a.m. Jan. 16, 2014 - TheStreet.com
Biogen, Celgene Lead 5 Top Large-Cap Drugmakers 7:05 a.m. Jan. 15, 2014 - Investors Business Daily
9 Biotechnology Stocks to Buy Now 6:30 a.m. Jan. 15, 2014 - InvestorPlace.com
ACOR Preliminary Q4 Revs Look Good - Analyst Blog 11:40 a.m. Jan. 14, 2014 - Zacks.com
Merck Turnaround Is Working Out Well 11:15 a.m. Jan. 14, 2014 - Barrons.com
Facebook, Other Big Cap 20 Leaders Fall In Low Volume 5:49 p.m. Jan. 13, 2014 - Investors Business Daily
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 4:00 p.m. Jan. 2, 2014 - BusinessWire
Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma 8:00 a.m. Dec. 31, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice 8:00 a.m. Dec. 17, 2013 - BusinessWire
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe 2:00 a.m. Dec. 17, 2013 - BusinessWire
Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America 8:00 a.m. Dec. 13, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼